References
Schroeder, S.A., Gaughan, D.M. & Swift, M. Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis. Nature Medicine 1, 703–705. (1995).
Mennie, M.F. et al. Prenatal screening for cystic fibrosis. Lancet 340, 214–217. (1992).
Meyers, D.A. & Marsh, D.G. Allergy and asthma. in The Genetic Basis of Common Diseases (eds King, R.A., Rotter, J.I. & Motulsky, A.G.) 130 (Oxford University Press, Oxford, 1992).
Capewell, S. Asthma in Scotland: epidemiology and clinical management. Health Bulletin 51, 118–127 (1993).
Livingstone, J. et al. Antenatal screening for cystic fibrosis: A trial of the couple model. Br. Med. J. 308, 1459–1462. (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mennie, M., Gilfillan, A., Brock, D. et al. Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med 1, 978–979 (1995). https://doi.org/10.1038/nm1095-978b
Issue Date:
DOI: https://doi.org/10.1038/nm1095-978b
- Springer Nature America, Inc.
This article is cited by
-
Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study
Respiratory Research (2005)
-
Association studies for asthma and atopic diseases: a comprehensive review of the literature
Respiratory Research (2003)
-
The cystic fibrosis heterozygote advantage
Nature Medicine (1995)
-
Reply to “The cystic fibrosis heterozygote advantage”
Nature Medicine (1995)